secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2026-08-03T20:15:50+00:00
Accession:  0001104659-26-089805
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransCode amends preferred stock certificate to remove 60-day notice for ownership limit changes
--------------------------------------------------------------------------------

- Second Amended and Restated Certificate of Designation filed on August 3, 2026.
- Removes 60-day notice requirement to change or waive beneficial ownership limitation.
- No other changes to the certificate; no additional securities issued or sold.
- Amendment approved by majority of preferred stockholders and Board of Directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465926089805/0001104659-26-089805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465926089805/tm2622073d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-089805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer